VACUETTE Blood Grouping tubes - Non-ridged (pull cap)
Navigation Links
VACUETTE Blood Grouping tubes - Non-ridged (pull cap)
| Products | VACUETTE Blood Grouping tubes - Non-ridged (pull cap) |
| Company | Greiner Bio-One |
| Item | VACUETTE Blood Grouping tubes - Non-ridged (pull cap) |
| Features | Inquire |
| Description | Blood grouping tubes are available in two formulations, ACD-A, ACD-B or with a CPDA solution. Blood grouping tubes are for blood grouping determinations and also for cell preservation. |
| Info | Greiner Bio-One Customer Service: (800) 884-4703 Web site: http://www.greinerbioone.com/ |
Related medicine products :
1. VACUETTE SRS 100/II
2. VACUETTE® SRS 20/II
3. VACUETTE® SRT 10/II
4. VACUETTE® Safety Blood Collection Sets
5. VACUETTE® Paediatric Winged Blood Collection Set
6. VACUETTE® Blood Collection Sets
7. VACUETTE® Tube Holders
8. VACUETTE EDTA tubes - Non-ridged (pull cap)
9. VACUETTE EDTA tubes - Ridged (safety screw cap)
10. VACUETTE EDTA K2 Gel Tubes - Ridged (safety screw cap)
11. VACUETTE Paediatric EDTA Tubes - Non-ridged (pull cap)
Breaking Medicine News(10 mins):Health News:The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession 2Health News:Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3Health News:Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5
[0] The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession[0] Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine [1] Obesity and Inactivity -- The Biggest Threat to the Nation's Health[0] Americans United for Life Action Fights the Abortion Bailout by Supporting the Nelson-Hatch-Casey Amendment[0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans
Other Medicine News:Health News:Increase In The Number Of Doctors Reporting About Their Colleagues Abilities 2Health News:Medicos Of The Calcutta Medical College Join Anti-Reservation Quota Protest 2Health News:Moderate Exercise, Key To Breast Cancer Prevention 2Health News:PAI-2 Plays a Pivotal Role in Eye Infections 2
Increase In The Number Of Doctors Reporting About Their Colleagues AbilitiesMedicos Of The Calcutta Medical College Join Anti-Reservation Quota ProtestNon Smoking Women Less Prone To Lung CancerModerate Exercise, Key To Breast Cancer PreventionCancer Cause Not Yet AscertainedPAI-2 Plays a Pivotal Role in Eye Infections
Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 1Appetite stimulating hormone is first potential medical treatment for frailty in older women 48756 2National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 1National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 2National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 3Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 1Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 2Healthcare Travel Congress 2009 3A Experts Worldwide Convene in Singapore For Regional Conference on Medical Tourism 48752 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |